EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mesenchymal Stem Cell-Derived Exosomes Attenuate Murine Cytomegalovirus-Infected Pneumonia via NF-κB/NLRP3 Signaling Pathway

Fei Chen, Zhida Chen, Hui-Ting Wu, Xin-Xiang Chen, Peiqi Zhan, Zheng-Yi Wei, Zizhang Ouyang, Xueyan Jiang iD, Ao Shen iD, Min-Hua Luo iD, Qifa Liu, Yue-Peng Zhou und 1 weitere

Viruses · 16.04.2024 · 16 (4) · 619

DOI: 10.3390/v16040619 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, online erschienen am 16.04.2024. Verfasst von Fei Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The NMPA and State Key Laboratory of Respira…. Hauptthemen laut MEDLINE: Exosomes, Mesenchymal Stem Cells, NLR Family, Pyrin Domain-Containing 3 Protein, NF-kappa B. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Qingyuan People's Hospital, the Sixth Affiliated Hospital of Guangzhou Medical University Open Project Fund, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Reactivation and infection with cytomegalovirus (CMV) are frequently observed in recipients of solid organ transplants, bone marrow transplants, and individuals with HIV infection. This presents an increasing risk of allograft rejection, opportunistic infection, graft failure, and patient mortality. Among immunocompromised hosts, interstitial pneumonia is the most critical clinical manifestation of CMV infection. Recent studies have demonstrated the potential therapeutic benefits of exosomes derived from mesenchymal stem cells (MSC-exos) in preclinical models of acute lung injury, including pneumonia, ARDS, and sepsis. However, the role of MSC-exos in the pathogenesis of infectious viral diseases, such as CMV pneumonia, remains unclear. In a mouse model of murine CMV-induced pneumonia, we observed that intravenous administration of mouse MSC (mMSC)-exos reduced lung damage, decreased the hyperinflammatory response, and shifted macrophage polarization from the M1 to the M2 phenotype. Treatment with mMSC-exos also significantly reduced the infiltration of inflammatory cells and pulmonary fibrosis. Furthermore, in vitro studies revealed that mMSC-exos reversed the hyperinflammatory phenotype of bone marrow-derived macrophages infected with murine CMV. Mechanistically, mMSC-exos treatment decreased activation of the NF-κB/NLRP3 signaling pathway both in vivo and in vitro. In summary, our findings indicate that mMSC-exo treatment is effective in severe CMV pneumonia by reducing lung inflammation and fibrosis through the NF-κB/NLRP3 signaling pathway, thus providing promising therapeutic potential for clinical CMV infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesMesenchymal Stem CellsNLR Family, Pyrin Domain-Containing 3 ProteinNF-kappa BSignal TransductionMuromegalovirusDisease Models, AnimalAnimalsMiceMice, Inbred C57BLMacrophagesCytomegalovirus InfectionsLungPneumonia, ViralHerpesviridae InfectionsPneumonia

Stichwörter der Autor:innen

NLRP3 inflammasomeexosomemesenchymal stem cellmurine cytomegaloviruspneumonia

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinNF-kappa BNlrp3 protein, mouse

Autor:innen und Institutionen

  • Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences and the Sixth Affiliat…
  • Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, Center for Cancer Research and Translational…
  • Department of Pharmaceutical Sciences, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan 511518, China.
  • State Key Laboratory of Virology, CAS Center for Excellence in Brain Science and Intelligence Technology (CEBSIT), Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China.
  • Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
  • State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, National Center for Magnetic Resonance in Wuhan, Wuhan Institute of Physics and Mathematics, Wuhan 430071, China.

ORCID-Profile: Xueyan Jiang, Ao Shen, Min-Hua Luo

Förderung

  • National Key Research and Development Program of China
  • Qingyuan People's Hospital, the Sixth Affiliated Hospital of Guangzhou Medical University Open Project Fund
  • National Natural Science Foundation of China
  • Qingyuan People’s Hospital, the Sixth Affiliated Hospital of Guangzhou Medical University Open Project Fund

Zitieren

APA

Chen, F., Chen, Z., Wu, H. T., Chen, X. X., Zhan, P., Wei, Z. Y., Ouyang, Z., Jiang, X., Shen, A., Luo, M. H., Liu, Q., Zhou, Y. P., & Qin, A. (2024). Mesenchymal Stem Cell-Derived Exosomes Attenuate Murine Cytomegalovirus-Infected Pneumonia via NF-κB/NLRP3 Signaling Pathway. Viruses, 16(4), 619. https://doi.org/10.3390/v16040619

Vancouver

Chen F, Chen Z, Wu HT, Chen XX, Zhan P, Wei ZY, et al. Mesenchymal Stem Cell-Derived Exosomes Attenuate Murine Cytomegalovirus-Infected Pneumonia via NF-κB/NLRP3 Signaling Pathway. Viruses. 2024;16(4):619. doi:10.3390/v16040619

BibTeX
@article{Chen2024,
  author = {Chen, Fei and Chen, Zhida and Wu, Hui-Ting and Chen, Xin-Xiang and Zhan, Peiqi and Wei, Zheng-Yi and Ouyang, Zizhang and Jiang, Xueyan and Shen, Ao and Luo, Min-Hua and Liu, Qifa and Zhou, Yue-Peng and Qin, Aiping},
  title = {Mesenchymal Stem Cell-Derived Exosomes Attenuate Murine Cytomegalovirus-Infected Pneumonia via NF-κB/NLRP3 Signaling Pathway},
  journal = {Viruses},
  year = {2024},
  volume = {16},
  number = {4},
  pages = {619},
  doi = {10.3390/v16040619}
}
Kostenlos starten →